NQF’s Measure Applications Partnership offers recommendations

The National Quality Forum’s (NQF) Measure Applications Partnership (MAP) has submitted recommendations to the Department of Health and Human Services (HHS) for approximately 140 performance measures under consideration for use in 16 federal healthcare programs.

The forum calls the measures a critical building block for national pay-for-performance and public reporting programs, which affect 55 million Americans enrolled in Medicare and their healthcare providers.

“The role of MAP continues to grow and evolve in reflection of the changing nature of our nation’s healthcare system and the increasing focus on using measurement to assess value,” said Helen Burstin, MD, MPH, NQF chief scientific officer. “MAP is recognized for the diverse perspectives and expertise it brings to the table from both the public and private sectors to come to consensus on recommended Medicare performance measures.”  

MAP’s recommendations are the result of a two-month process in which experts review measures under HHS consideration for use in clinician, hospital and post-acute care/long-term care settings; assimilate public comments; and make recommendations about each measure. HHS then considers MAP recommendations in selecting measures for use in federal healthcare programs.

This year’s annual review of measures under consideration includes the following themes:

  • Identifying measurement gaps, or areas where more research and data are needed, particularly in areas such as mental/behavioral health, perinatal care, and pediatric health, among others;
  • Increasing alignment around key quality issues across federal programs to eliminate duplicative measurement;
  • Sharing information about measure use to identify trends in performance and ensure measures are working as intended; and
  • Continuously assessing areas in which care coordination among various providers can improve health and healthcare quality as well as the patient experience.

Approximately 60 of the measures are proposed for use in the Merit-Based Incentive Payment System (MIPS), a Centers for Medicare & Medicaid Services (CMS) program legislated by the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA).

Additional MAP reports on the themes and measurement issues in the post-acute and long-term care settings and hospital settings will be published on February 12. MAP reports on themes for clinician settings and cross-cutting issues will be published March 15.

Read the final measure recommendation report.

Beth Walsh,

Editor

Editor Beth earned a bachelor’s degree in journalism and master’s in health communication. She has worked in hospital, academic and publishing settings over the past 20 years. Beth joined TriMed in 2005, as editor of CMIO and Clinical Innovation + Technology. When not covering all things related to health IT, she spends time with her husband and three children.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.